Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops

被引：0

作者：

Eto, Ryo ^{[1
]}

Kawano, Hiroaki

Suzuki, Ayaka

Akashi, Ryohei

Ikeda, Satoshi

Maemura, Koji

机构：

[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki, Japan

来源：

INTERNAL MEDICINE | 2023年 / 62卷 / 17期

关键词：

vasospastic angina; ophthalmic beta-blocker; carteolol; SPASM; ASTHMA;

D O I：

10.2169/internalmedicine.0495-22

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vasospastic angina (VSA) can be worsened by oral nonselective beta-blockers. Ophthalmic carteolol eye drops are nonselective beta-blockers and effective against glaucoma and ocular hypertension. Systemic effects of ophthalmic beta-blockers on VSA have not yet been reported. We herein report a case of VSA that developed after a patient started carteolol eye drops for ocular hypertension. Even though benidipine, a calcium channel blocker, was started, a VSA attack with incessant non-sustained ventricular tachycardia occurred. Once the carteolol eyedrops were discontinued, the VSA resolved. This case demonstrates that carteolol eye drops can induce life-threatening VSA.

引用

页码：2513 / 2516

页数：4

共 18 条

[1] CORONARY-ARTERY SPASM INDUCED BY PHENYLEPHRINE EYEDROPS [J].

ALDER, AG ;

MCELWAIN, GE ;

MARTIN, JH ;

JEGLUM, EL .

ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (10) :1384-1385

[2] Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease [J].

Arai, Riku ;

Fukamachi, Daisuke ;

Monden, Masaki ;

Akutsu, Naotaka ;

Murata, Nobuhiro ;

Okumura, Yasuo .

INTERNAL MEDICINE, 2021, 60 (01) :79-83

[3] Asthma mortality in Australia in the 21st century: a case series analysis [J].

Goeman, Dianne P. ;

Abramson, Michael J. ;

McCarthy, Edwina A. ;

Zubrinich, Celia M. ;

Douglass, Jo A. .

BMJ OPEN, 2013, 3 (05)

[4] Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers [J].

Ito, A ;

Fukumoto, Y ;

Shimokawa, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (04) :480-485

[5] Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops [J].

Korte, JM ;

Kaila, T ;

Saari, KM .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (06) :430-435

[6] Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials [J].

Morales, Daniel R. ;

Dreischulte, Tobias ;

Lipworth, Brian J. ;

Donnan, Peter T. ;

Jackson, Cathy ;

Guthrie, Bruce .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (03) :814-822

[7] RETRACTED: Prescribing of β-adrenoceptor antagonists in asthma: an observational study (Retracted Article) [J].

Morales, Daniel R. ;

Guthrie, Bruce ;

Lipworth, Brian J. ;

Donnan, Peter T. ;

Jackson, Cathy .

THORAX, 2011, 66 (06) :502-507

[8] CLINICAL CHARACTERISTICS ASSOCIATED WITH MYOCARDIAL-INFARCTION, ARRHYTHMIAS, AND SUDDEN-DEATH IN PATIENTS WITH VASOSPASTIC ANGINA [J].

NAKAMURA, M ;

TAKESHITA, A ;

NOSE, Y .

CIRCULATION, 1987, 75 (06) :1110-1116

[9] Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma [J].

Netland, PA ;

Weiss, HS ;

Stewart, WC ;

Cohen, JS ;

Nussbaum, LL ;

Abrams, D ;

Schwartz, G ;

Hughes, P ;

Adelson, A ;

Brink, M ;

Myers, M ;

Bahr, R ;

Dowling, JL ;

Richards, F ;

Geltzer, A ;

Hofmann, RJ ;

SnadyMcCoy, L ;

Bartnik, LA ;

Beneke, J ;

Barr, L ;

Muroski, D ;

Neal, J ;

Clevenger, C ;

Summitt, B ;

Lee, A ;

Cohen, J ;

Riccio, KA ;

Luechauer, A ;

DuBiner, H ;

Cribbs, S ;

Laibovitz, R ;

Neck, K ;

Mundorf, T ;

Otero, D ;

Netland, PA ;

Vivolo, DA ;

Schwartz, L ;

Carmichael, P ;

Conner, R ;

Nowinski, T ;

Kesselring, J ;

Bollenbach, A ;

Foley, A ;

Stewart, W ;

Stewart, J ;

Weiss, H ;

Schwartz, A ;

Latham, BD .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (04) :465-477

[10]

ODEH M, 1991, J FAM PRACTICE, V32, P97

← 1 2 →